PGNX

PROGENICS PHARMACEUTICALS

6.0000
USD
2.04%
6.0000
USD
2.04%
5.0100 9.4172
52 weeks
52 weeks

Mkt Cap 503.10M

Shares Out 83.85M

new Chat
Send me real-time posts from this site at my email

Valeant, Progenics shares rise on constipation drug approval

Valeant Pharmaceuticals International Inc. VRX, +0.17% and Progenics Pharmaceuticals Inc. PGNX, -8.52% said late Tuesday the Food and Drug Administration approved their drug Relistor to treat...


More
Followers
8